Related Experiment Video
Updated: Apr 1, 2026

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
Published on: June 30, 2021
Microbiome as mediator: Do systemic infections start in the gut?
Melissa Latorre1, Suneeta Krishnareddy1, Daniel E Freedberg1
1Melissa Latorre, Suneeta Krishnareddy, Daniel E Freedberg, Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY 10023, United States.
Abstract:
The intestinal microbiome is emerging as a crucial mediator between external insults and systemic infections. New research suggests that our intestinal microorganisms contribute to critical illness and the development of non-gastrointestinal infectious diseases. Common pathways include a loss of fecal intestinal bacterial diversity and a disproportionate increase in toxogenic bacterial species. Therapeutic interventions targeting the microbiome - primarily probiotics - have yielded limited results to date. However, knowledge in this area is rapidly expanding and microbiome-based therapy such as short-chain fatty acids may eventually become a standard strategy for preventing systemic infections in the context of critical illness.
Insights
The gut microbiome influences critical illness and infections by altering bacterial diversity. Future therapies like short-chain fatty acids show promise for preventing systemic infections.
Area of Science:
- Microbiology
- Immunology
- Critical Care Medicine
Background:
- The intestinal microbiome plays a key role in mediating between external factors and systemic infections.
- Alterations in gut microbial composition, including reduced bacterial diversity and increased toxogenic species, are linked to critical illness and non-gastrointestinal infections.
Discussion:
- Current microbiome-targeted therapies, such as probiotics, have shown limited efficacy.
- Understanding the complex interplay between the gut microbiome and host immunity is crucial for developing effective treatments.
Key Insights:
- Loss of fecal bacterial diversity and overgrowth of specific bacterial species are common in critical illness.
- The gut microbiome is a significant factor in the development of systemic and non-gastrointestinal infectious diseases.
Outlook:
- Microbiome-based therapies, including short-chain fatty acids, are a promising future strategy.
- Further research is needed to fully elucidate the role of the microbiome in critical illness and to optimize therapeutic interventions.
More Related Videos
11:22Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
09:49Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection
Published on: November 18, 2022
Related Concept Videos
Functions of the Gut Microbiota
The Oral Microbiota
Introduction to the Human Microbiota
Gut-Brain Axis
Microbiota of the Large Intestine
Microbiota of the Respiratory Tract